BioCentury | Mar 27, 2000
Finance

'No dessert, thank you'

...cancer company at $410.9 million. Johnson & Johnson Development Corp., Oak Investment Partners, Sprout Capital, Marquette Venture Partners...
BioCentury | Jan 31, 2000
Finance

Here comes the paper

...in brain metastases. Investors including Oak Investment Partners, Sprout Capital, Johnson & Johnson Development Corp., Marquette Venture Partners...
BioCentury | Apr 22, 1996
Finance

Muscling In

...Ventures, will be reduced to 21 percent. A group of VCs - including Columbine Ventures; Marquette Venture Partners...
Items per page:
1 - 3 of 3
BioCentury | Mar 27, 2000
Finance

'No dessert, thank you'

...cancer company at $410.9 million. Johnson & Johnson Development Corp., Oak Investment Partners, Sprout Capital, Marquette Venture Partners...
BioCentury | Jan 31, 2000
Finance

Here comes the paper

...in brain metastases. Investors including Oak Investment Partners, Sprout Capital, Johnson & Johnson Development Corp., Marquette Venture Partners...
BioCentury | Apr 22, 1996
Finance

Muscling In

...Ventures, will be reduced to 21 percent. A group of VCs - including Columbine Ventures; Marquette Venture Partners...
Items per page:
1 - 3 of 3